Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2019-11-08 2019-11-08
Drug Identification Number 01990748 01990748
Brand name HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION
Common or Proper name Heparin Sodium in Sodium Chloride Injection Heparin Sodium in Sodium Chloride Injection
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients HEPARIN SODIUM HEPARIN SODIUM
Strength(s) 2UNIT 2UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 18 x 500ml PLBG 18 x 500ml PLBG
ATC code B01AB B01AB
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-11-07 2019-11-07
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Inventory is on preventative allocation. Increased demand due to competitive backorder. Inventory is on preventative allocation. Increased demand due to competitive backorder.
Health Canada comments